Go to Content Go to Navigation Go to Navigation Go to Site Search Homepage

Planned Parenthood Calls on FDA to Stop Playing Politics and to Focus on Science and Public Health

Source

Planned Parenthood Federation of America

Contact

WASHINGTON, DC — Following reports today that the U.S. Food and Drug Administration (FDA) will discuss over-the-counter status with Barr Pharmaceuticals, the maker of Plan B emergency contraception (EC), Planned Parenthood Federation of America (PPFA) called on officials at the FDA to stop playing politics with women's reproductive health.

"Today's announcement holds the potential for improving women's health if the FDA keeps its word this time. The FDA should be on the frontlines of advancing public health, and expanded access to contraception is the best way to prevent unintended pregnancies for women of all reproductive ages," said Vanessa Cullins, M.D., PPFA vice president for medical affairs.

News reports indicate the FDA and Barr plan to discuss granting over-the-counter status to EC for women 18 and over, leaving younger women without the benefits of greater access to the backup birth control method. The announcement comes one day before Andrew von Eschenbach, whom President Bush has nominated to become commissioner of the FDA, is scheduled to appear at a Senate hearing. As acting commissioner of the agency, von Eschenbach has taken no action on EC and Senators Clinton and Murray have pledged to hold his nomination until the FDA makes a final decision on the Plan B application.

"The FDA has made false promises before on women's access to EC over the counter. Their needless delay on this issue is now more than 550 days old — in that time women could have prevented an estimated 2.25 million unintended pregnancies and 1.2 million abortions if EC were available over the counter. Women deserve to have the FDA approve this immediately. Planned Parenthood calls on the FDA to stop this shameful game of false promises and playing politics with its public health mandate," added Dr. Cullins.

EC lowers the risk of pregnancy when started within 120 hours of unprotected intercourse. Experts estimate that wider access to EC could prevent up to 1.5 million unintended pregnancies — and 800,000 abortions — a year. The sooner EC is administered after unprotected intercourse, the better it works, making timely access critically important. Studies show that women do not use EC as a regular method of birth control.

 

Published

July 31, 2006

###

Planned Parenthood is the nation’s leading provider and advocate of high-quality, affordable health care for women, men, and young people, as well as the nation’s largest provider of sex education. With more than 700 health centers across the country, Planned Parenthood organizations serve all patients with care and compassion, with respect and without judgment. Through health centers, programs in schools and communities, and online resources, Planned Parenthood is a trusted source of reliable health information that allows people to make informed health decisions. We do all this because we care passionately about helping people lead healthier lives.

Source

Planned Parenthood Federation of America

Contact

Erin Kiernon, 202-973-4975
Andrea Hagelgans (646)-369-8617

Published

July 31, 2006

Planned Parenthood cares about your data privacy. We and our third-party vendors use cookies and other tools to collect, store, monitor, and analyze information about your interaction with our site to improve performance, analyze your use of our sites and assist in our marketing efforts. You may opt out of the use of these cookies and other tools at any time by visiting Cookie Settings. By clicking “Allow All Cookies” you consent to our collection and use of such data, and our Terms of Use. For more information, see our Privacy Notice.

Cookie Settings

Planned Parenthood cares about your data privacy. We and our third-party vendors, use cookies, pixels, and other tracking technologies to collect, store, monitor, and process certain information about you when you access and use our services, read our emails, or otherwise engage with us. The information collected might relate to you, your preferences, or your device. We use that information to make the site work, analyze performance and traffic on our website, to provide a more personalized web experience, and assist in our marketing efforts. We also share information with our social media, advertising, and analytics partners. You can change your default settings according to your preference. You cannot opt-out of required cookies when utilizing our site; this includes necessary cookies that help our site to function (such as remembering your cookie preference settings). For more information, please see our Privacy Notice.

Marketing

On

We use online advertising to promote our mission and help constituents find our services. Marketing pixels help us measure the success of our campaigns.

Performance

On

We use qualitative data, including session replay, to learn about your user experience and improve our products and services.

Analytics

On

We use web analytics to help us understand user engagement with our website, trends, and overall reach of our products.